Latest Breaking News On - Commercial molecular - Page 1 : comparemela.com

SUNNYVALE, Calif., Dec. 8, 2022 /PRNewswire/ Currently circulating mutant strains of influenza highlight the need for multi-target diagnostic tests. Two recently identified mutations in the

United statesUnited kingdomDarwa petersonMike loeffelholzDavid persingScientific affairsHealthcare products regulatory agencyOur scientific affairsHuman influenzaChief scientific officerGene targetSenior directorMatrix gene causingNegative resultCommercial molecularVitro diagnostic medical